Glaucoma is the second leading cause of blindness in the world and the leading cause of blindness among Africans Americans. Primary congenital glaucoma (PCG) is the most common childhood glaucoma. A notable subtype, newborn PCG, may often have the most severe and clinically challenging expression. Mutations in the CYP1B1 gene are responsible for >50% of cases in some populations.
Tests generally appear in the order most useful for common clinical situations
| Test name: Glaucoma (Primary Congenital), CYP1B1 Sequencing |
| ARUP #: 0051476 |
| Methodology: Polymerase Chain Reaction/Sequencing |
| Use: Identify mutations responsible for glaucoma Clinical sensitivity: 20-100% in familial cases, 10-15% in isolated cases |
| Limitations: Large gene deletions/duplications and deep intronic mutations will not be detected |